An audit study on management of anemia and hypertension among children with chronic kidney disease admitted to Assiut University Children Hospital

Introduction
Given the progressive nature of chronic kidney disease (CKD) and the complexity of the treatment regimen, it is important that nurses be comfortable in implementing acute and preventive care strategies and facilitating the coordination of care. In addition, the need for multiple therapies can be distressing for patients and their families, further supporting the role of the nurse in patient and family education and decision making regarding the plan of care.
Patients and methods
Clinical examination results about manifestations related to anemia and hypertension (HT) were taken from recorded data in Nephrology Unit, in addition to asking patients' relatives directly. Management of anemia was done by oral iron (dose 6 mg/kg/day) and subcutaneous erythropoietin every 3 days (100 IU/kg/dose). Management of HT was by Angiotensin converting enyme inhibitors (ACEIs) (1 mg/kg/day) and Angiotensin receptor blockers (ARBs) (0.7 mg/kg/dose).
Results
The most common cause of CKD in our study was congenital anomalies (56%). Clinical evaluation of the studied patients was done perfectly except for defects in history taking, such as edema, epistaxis, and the increased frequency of assessment hemoglobin level. Management of anemia was nearly done for all cases. All studied cases of CKD had controlled HT according to the used protocol of management.
Conclusion
Anemia and HT are the most common complications to occur in CKD (83% in our study). Management of anemia and HT of the studied patients was perfectly done, except for defects in history taking.